‘Cutting red tape,’ mental health and primary care on the health docket this fall
Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers are priorities.
Canada at risk of collateral damage in U.S. drug pricing war
A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
U.S. tariffs on pharmaceuticals could complicate an already complex supply chain
Drug companies could begin questioning whether to manufacture drugs or conduct clinical trials in Canada, says Life Sciences Ontario CEO.
A different ‘philosophy’ steers new drug pricing guidelines, says top PMPRB bureaucrat after contentious path to rule changes
Guideline changes became necessary after Justin Trudeau’s government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
Canada’s next top doctor must be a ‘focal point’ for public health amid changes in the U.S., concerns about next pandemic
Dr. Theresa Tam has left the job of chief public health officer after eight years. Her successor will have to contend with a change in the U.S.’ public health approach, vaccine hesitancy among Canadians and the need to always be ready for the next global outbreak.
From momentum to leadership: securing Canada’s biotech future
To lead in this space, Canada needs a globally competitive investment climate, and a best-in-class regulatory system.
Biotech
Canada needs to catch up in the biotech sector
Currently, our scientists have to look outside of the country to take their work to the next level, which means that Canada is not benefitting fully from Canadian ideas.
Unlocking Canada’s greatest economic potential: life sciences
The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can help solve some of our biggest societal challenges.
Canada’s biotech carpe diem
It’s imperative Canada keep pace with other competing jurisdictions, and establish itself as a regulatory leader that rewards investment and talent.
